392 related articles for article (PubMed ID: 9219787)
1. Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study.
d'Albasio G; Pacini F; Camarri E; Messori A; Trallori G; Bonanomi AG; Bardazzi G; Milla M; Ferrero S; Biagini M; Quaranta S; Amorosi A
Am J Gastroenterol; 1997 Jul; 92(7):1143-7. PubMed ID: 9219787
[TBL] [Abstract][Full Text] [Related]
2. Combined therapy with 5-aminosalicylic tablets and enemas for maintaining remission in ulcerative colitis.
d'Albasio G; Trallori G; Gavazzi O; Bardazzi G; Vannozzi G; Frittelli G; Cini E; Falai T; Varini C; Morettini A
Ital J Gastroenterol; 1991 Jan; 23(1):12-4. PubMed ID: 1747494
[TBL] [Abstract][Full Text] [Related]
3. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis.
Andreoli A; Spinella S; Levenstein S; Prantera C
Ital J Gastroenterol; 1994 Apr; 26(3):121-5. PubMed ID: 7914759
[TBL] [Abstract][Full Text] [Related]
4. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis.
Safdi M; DeMicco M; Sninsky C; Banks P; Wruble L; Deren J; Koval G; Nichols T; Targan S; Fleishman C; Wiita B
Am J Gastroenterol; 1997 Oct; 92(10):1867-71. PubMed ID: 9382054
[TBL] [Abstract][Full Text] [Related]
5. A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults.
Kam L; Cohen H; Dooley C; Rubin P; Orchard J
Am J Gastroenterol; 1996 Jul; 91(7):1338-42. PubMed ID: 8677990
[TBL] [Abstract][Full Text] [Related]
6. Beclomethasone dipropionate (3 mg) enemas combined with oral 5-ASA (2.4 g) in the treatment of ulcerative colitis not responsive to oral 5-ASA alone.
D'Arienzo A; Manguso F; Castiglione GN; Vicinanza G; Scaglione G; Bennato R; Sanges M; Mazzacca G
Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):254-7. PubMed ID: 9759590
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group.
Rutgeerts P
Aliment Pharmacol Ther; 1989 Apr; 3(2):183-91. PubMed ID: 2577483
[TBL] [Abstract][Full Text] [Related]
8. Intermittent versus continuous 5-aminosalicylic acid treatment for maintaining remission in ulcerative colitis.
Bardazzi G; d'Albasio G; Bonanomi AG; Trallori G; Messori A; Amorosi A; Bartoletti L; Morettini A; Pacini F
Ital J Gastroenterol; 1994 Sep; 26(7):334-7. PubMed ID: 7812025
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis.
Sinha A; Nightingale J; West KP; Berlanga-Acosta J; Playford RJ
N Engl J Med; 2003 Jul; 349(4):350-7. PubMed ID: 12878742
[TBL] [Abstract][Full Text] [Related]
10. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial.
Friedman LS; Richter JM; Kirkham SE; DeMonaco HJ; May RJ
Am J Gastroenterol; 1986 Jun; 81(6):412-8. PubMed ID: 3518408
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX with Asacol.
Prantera C; Kohn A; Campieri M; Caprilli R; Cottone M; Pallone F; Savarino V; Sturniolo GC; Vecchi M; Ardia A; Bellinvia S
Aliment Pharmacol Ther; 2009 Nov; 30(9):908-18. PubMed ID: 19678813
[TBL] [Abstract][Full Text] [Related]
12. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
[TBL] [Abstract][Full Text] [Related]
13. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H
Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519
[TBL] [Abstract][Full Text] [Related]
14. 5-Aminosalicylic acid suppositories in the maintenance of remission in idiopathic proctitis or proctosigmoiditis: a double-blind placebo-controlled clinical trial.
D'Arienzo A; Panarese A; D'Armiento FP; Lancia C; Quattrone P; Giannattasio F; Boscaino A; Mazzacca G
Am J Gastroenterol; 1990 Sep; 85(9):1079-82. PubMed ID: 2202199
[TBL] [Abstract][Full Text] [Related]
15. Long-term intermittent treatment with low-dose 5-aminosalicylic enemas is efficacious for remission maintenance in ulcerative colitis.
Piodi LP; Ulivieri FM; Cermesoni L; Cesana BM
Scand J Gastroenterol; 2004 Feb; 39(2):154-7. PubMed ID: 15000277
[TBL] [Abstract][Full Text] [Related]
16. Low Pentasa dosage versus hydrocortisone in the topical treatment of active ulcerative colitis: a randomized, double-blind study.
Bianchi Porro G; Ardizzone S; Petrillo M; Fasoli A; Molteni P; Imbesi V
Am J Gastroenterol; 1995 May; 90(5):736-9. PubMed ID: 7733079
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
Levine DS; Riff DS; Pruitt R; Wruble L; Koval G; Sales D; Bell JK; Johnson LK
Am J Gastroenterol; 2002 Jun; 97(6):1398-407. PubMed ID: 12094857
[TBL] [Abstract][Full Text] [Related]
18. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
Habal FM; Greenberg GR
Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391
[TBL] [Abstract][Full Text] [Related]
19. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: long-term results.
Guarino J; Chatzinoff M; Berk T; Friedman LS
Am J Gastroenterol; 1987 Aug; 82(8):732-7. PubMed ID: 3496786
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
Mantzaris GJ; Sfakianakis M; Archavlis E; Petraki K; Christidou A; Karagiannidis A; Triadaphyllou G
Am J Gastroenterol; 2004 Jun; 99(6):1122-8. PubMed ID: 15180735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
